Sun Pharmaceutical Gets CDSCO Panel Nod To import, market plaque psoriasis drug Tildrakizumab injection Dr. Divya Colin2 March 2025 6:00 PM ISTNew Delhi: Pharmaceutical major Sun Pharmaceutical has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Indian pharma firms lag behind global peers in RnD, Patents, Publications, reveals report MD Bureau21 Oct 2024 2:15 PM ISTThe largest disparity was observed in the number of publications per billion USD revenue, with global firms producing 8.4 times more publications than...
CDSCO panel agrees with Sun Pharmaceutical's Phase IV Trial Results of Cephalexin plus Clavulanate Potassium Tablets Dr. Divya Colin16 May 2024 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has agreed to the Phase IV...
Folzest Vs Forzest: Delhi HC stays order involving Rs10 lakh penalty on Sun Pharma Tanya Bhutani9 Dec 2022 6:00 PM ISTDelhi: In a major relief to Sun Pharmaceuticals Ltd., the Delhi High Court has issued an order staying its earlier order in November that had imposed...
Sun Pharma Shares Under freefall: Co announces Investor Update Call on December 03, 2018; 6.30 pm Medical Dialogues Bureau3 Dec 2018 2:56 PM ISTMumbai: Share price of Sun Pharmaceutical, the largest pharma company in the country, have been witnessing a free fall since morning, as a result of...
Domestic medicines face quality lapses, says govt task force Pooja Bhatia Bhatia28 Jan 2016 11:17 AM ISTThe task force set up by the department of pharmaceuticals (DoP) under the Indian government banner to monitor the domestic pharmaceutical production,...
Sun Pharma raises Rs 1,000 cr via NCDs savita thakur thakur25 Dec 2015 11:19 AM ISTNew Delhi: Drug major Sun Pharma Industries said it has raised Rs 1,000 crore through issuance of non-convertible debentures (NCDs) on private...
Sun Pharma to discontinue non-strategic business units Meghna A Singhania2 Nov 2015 11:08 AM ISTAs a part of its integration process with Ranbaxy Laboratories, Sun Pharma is likely to discontinue certain non-strategic businesses to have a smooth...
Sun Pharma settles patent litigation with Acorda Therapeutics Meghna A Singhania22 Oct 2015 10:37 PM ISTNEW DELHI: Sun Pharma has settled a patent litigation with US-based Acorda Therapeutics Inc over Ampyra extended-release tablets, which is used in the...
FDA revokes approval for Sun Pharma 's seizure drug over compliance issues Meghna A Singhania27 Sept 2015 12:55 PM ISTThe U.S. Food and Drug Administration has revoked an approval issued in March to India's Sun Pharma Advanced Research Company Ltd (SPARC) to launch a...
Sun Pharmaceuticals to establish ophthalmic business in the US Pooja Bhatia Bhatia17 Sept 2015 12:56 PM ISTDrug major Sun Pharmaceuticals has set its eye on the branded ophthalmic business in the US with the recent acquisition of InSite Vision Inc, a US...
